LI
Insider
Lilly Endowment Inc
OtherLilly Endowment Inc (Other) filed 35 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 35 sales, 1 filed past the two-business-day deadline), most often in Eli Lilly and Company (LLY). The largest single filing was $75.9B of LLY (178,295 sh across 4 lots, as filed), executed Nov 14 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
35
0 buys · 35 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$79.3B
shares × price, as filed
Last traded
May 6
Filed May 7
Median ADV $3.8B across their filed names
Open performance→Volume by month
Buys $0
Sells $82.0B
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
34 filings
Sector per market data · by filing · past 12 months
Most traded names
LLYRecent filings
LLYSALE
Eli Lilly and Company
View filing →
$308.4M305,000 sh across 20 lots
Exec Nov 12 2025
Filed Nov 13 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $279.3M
283,131 sh across 27 lots
Exec Nov 11 2025
Filed Nov 12 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $16.4M
16,869 sh across 3 lots
Exec Nov 10 2025
Filed Nov 12 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $167.1M
179,042 sh across 30 lots
Exec Nov 5 2025
Filed Nov 6 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $38.5M
40,432 sh across 8 lots
Exec Nov 5 2025
Filed Nov 6 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $479K
526 sh × $910.72
Exec Nov 4 2025
Filed Nov 5 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $266.6M
300,000 sh across 24 lots
Exec Nov 3 2025
Filed Nov 4 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $260.2M
301,342 sh across 8 lots
Exec Oct 31 2025
Filed Nov 3 2025 · 5:30 PM ET More filings →